GL1X · GenesisL1 explorer

MolNFT v1 · #3037 · protein

Convergence of catalytic antibody and terpene cyclase mechanisms: polyene cyclization directed by carbocation-pi interactions

1CF8 · Protein (catalytic antibody 19A4 (light chain)): “Convergence of catalytic antibody and terpene cyclase mechanisms: polyene cyclization directed by…”. X-ray diffraction, 2 ligands (HAZ, CD), 4 pockets (best druggability 0.71).…

PDB
1CF8
Type
protein
Length
433 residues
Chains
2
Method
x-ray diffraction
Collection
MolNFT v1 / PDB
Contract
0xDE3723766Bc32dcACD03C17BaA400A7B36837Eba
Owner
0x3396CDB397284571d12822B4ae1189a8E22AAAAA
Molecule
Protein (catalytic antibody 19A4 (light chain)); Protein (catalytic antibody 19A4 (heavy…
Ligands
HAZ, CD
Pockets
4 · best druggability 0.71

Structure

x-ray diffraction · 2 distinct chains · 5% helix, 53% strand (DSSP).

ChainMoleculeTypeResiduesSecondary structureUniProt
LProtein (catalytic antibody 19A4 (light chain))protein2157% helix, 52% strand—
HProtein (catalytic antibody 19A4 (heavy chain))protein2184% helix, 53% strand—

Ligands and binding sites

  • HAZ · 4-{4-[2-(1A,7A-dimethyl-4-oxy-octahydro-1-oxa-4-aza-cyclopropa[a]naphthalen-4-yl) -acetylamino]-phenylcarbamoyl}-butyric acid · ligand · chains L, H
  • CD · Cadmium ion · metal · 2 copies · chains L, H

Binding sites are the residues within 4.5 Å of a ligand's heavy atoms.

Pockets

4 pockets found on a 1 Å grid, 3 with a druggability of 0.5 or more.

PocketVolume (ų)DruggabilityBuriednessLining residuesInside
11480.710.9021HAZ
22270.550.7831CD
33190.540.7545empty
4650.290.7417empty

Interfaces

1 interface between chains.

  • L–H · 1857 Ų buried · 11 hydrogen bonds · protein-protein

Modifications

Observed in the structure: 5 disulfide (disulfide).

Compared structures

  • 1CF8 · Convergence of catalytic antibody and terpene cyclase mechanisms: polyene cyclization… · the same entry in another collection · chain L against L, TM-score 1.00

Analyse

GL1X is a live explorer of the GenesisL1 blockchain. Turn on JavaScript for search, charts and interactive views.